Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (4)

Search Parameters:
Keywords = non-ischemic priapism

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
18 pages, 973 KB  
Article
Prevalence and Predictors of Priapism Among Patients with Sickle Cell Disease: A Cross-Sectional Study
by Mortadah Alsalman, Jawad Alnajjar, Ridha Alhussain, Abdulah Alshakhs, Zainab Alkhmis, Abdullah Alghafli, Hassan Alradhi, Mujtaba Alzuwayr, Nawal Eltayeb Omer Mohammed, Zaenb Alsalman and Ahmed Al-Suliman
Medicina 2026, 62(2), 278; https://doi.org/10.3390/medicina62020278 - 28 Jan 2026
Viewed by 1716
Abstract
Background and Objectives: Priapism, most commonly the ischemic (low-flow) type, is a debilitating complication affecting males with sickle cell disease (SCD), making prevention a critical aspect of care. This study aimed to determine the prevalence of priapism and identify its associated predictors [...] Read more.
Background and Objectives: Priapism, most commonly the ischemic (low-flow) type, is a debilitating complication affecting males with sickle cell disease (SCD), making prevention a critical aspect of care. This study aimed to determine the prevalence of priapism and identify its associated predictors among adult patients with SCD. Materials and Methods: This cross-sectional study was conducted at the Hereditary Blood Disorder Centre in the Eastern Province of Saudi Arabia from February 2024 to August 2025. Results: A total of 240 male SCD patients were included, of whom 33 (13.8%) reported a lifetime history of priapism. The median age at the first priapism episode was 29 years. Multivariate logistic regression identified a history of blood transfusion as the only significant independent predictor of priapism (aOR = 10.36, 95% CI: 1.32–81.14, p = 0.026). Episode frequency varied, with 33.3% of affected patients reporting episodes occurring monthly or less than weekly. Regarding timing, 45.5% of episodes occurred during sleep, while 27.3% occurred in the early morning hours. Kaplan–Meier survival curves indicated that patients receiving hydroxyurea experienced priapism at significantly younger ages compared with non-users (95% CI: 23–33 years). This difference was confirmed by a statistically significant log-rank test (p = 0.012), indicating a more rapid decline in the probability of remaining priapism-free with increasing age among hydroxyurea users. Conclusions: Priapism in SCD remains a significant clinical challenge despite available therapeutic options. Transfusion burden, alongside previously recognized predictors, serves as a key indicator of priapism risk and underscores the importance of early identification and intervention. Although hydroxyurea is effective in managing several complications of sickle cell disease, priapism was observed in patients despite its use, and episodes continued to occur with increasing age; however, these findings may be influenced by confounding factors such as age, disease severity, and transfusion history. Full article
(This article belongs to the Section Hematology and Immunology)
Show Figures

Figure 1

10 pages, 265 KB  
Article
The Management of Ischemic Priapism Due to Sickle Cell Disease and Other Etiologies: Treatment Strategies and Indications for Penile Prosthesis Implantation in an Endemic Region
by Eser Ördek, Sadık Görür, Fatih Gökalp, Duran Kuru and Ferhat Uçurmak
Medicina 2025, 61(4), 658; https://doi.org/10.3390/medicina61040658 - 3 Apr 2025
Cited by 3 | Viewed by 3900
Abstract
Background and Objectives: Priapism is a condition characterized by a prolonged erection lasting over four hours, either independent of or following sexual stimulation. The primary treatment goal for ischemic and non-ischemic priapism is timely and appropriate intervention in order to preserve erectile [...] Read more.
Background and Objectives: Priapism is a condition characterized by a prolonged erection lasting over four hours, either independent of or following sexual stimulation. The primary treatment goal for ischemic and non-ischemic priapism is timely and appropriate intervention in order to preserve erectile function and penile length. This study aims to evaluate the management of recurrent ischemic priapism in sickle cell disease (SCD) patients in an endemic region and compare it with ischemic priapism of other etiologies. Materials and Methods: Patients admitted to our hospital with a diagnosis of priapism between January 2010 and June 2024 were retrospectively reviewed. The patients were divided into two groups: ischemic priapism due to SCD and ischemic priapism due to other etiologies. Patient characteristics, treatment management, and the need for penile prosthesis (PP) were compared. Results: A total of 40 ischemic priapism patients were included in the study; 20 of them had SCD and the other 20 had priapism cases due to different etiologies. In the SCD priapism group, the rate of comorbidity and previous history of priapism were significantly (p < 0.05) higher than in the other etiologies of priapism group. Similarly, in the SCD priapism group, the hospital admission time and the rate of fibrosis findings in MRI (magnetic resonance imaging) were significantly (p < 0.05) higher than in the other priapism groups. The PP implantation rate in the SCD priapism group was found to be significantly (p < 0.05) higher than in the other priapism group. Conclusions: This study highlights the importance of early intervention and patient awareness in SCD-related ischemic priapism, recommending educational programs to improve symptom recognition and prevent complications. Full article
12 pages, 4851 KB  
Case Report
Stuttering Priapism in a Dog—First Report
by Françoise A. Roux, Florian Le Breuil, Julien Branchereau and Jack-Yves Deschamps
Vet. Sci. 2022, 9(10), 518; https://doi.org/10.3390/vetsci9100518 - 23 Sep 2022
Cited by 3 | Viewed by 31414
Abstract
A 5-year-old recently castrated male Doberman dog presented for prolonged erection of one week’s duration with associated pain and dysuria. This was the fourth episode within a year. Each episode was associated with an unusual event, which was stressful for the dog. Castration [...] Read more.
A 5-year-old recently castrated male Doberman dog presented for prolonged erection of one week’s duration with associated pain and dysuria. This was the fourth episode within a year. Each episode was associated with an unusual event, which was stressful for the dog. Castration performed two months prior to the final episode did not prevent recurrence. Due to tissue necrosis, penile amputation and urethrostomy had to be performed. The dog recovered fully. Prolonged erection that persists beyond or that is unrelated to sexual stimulation is called “priapism”. This term refers to the Greek god Priapus, a god of fertility, memorialized in sculptures for his giant phallus. In humans, depending on the mechanism involved, priapism is classified as nonischemic or ischemic. Because prognosis and treatment are different, priapism must be determined to be nonischemic or ischemic. Nonischemic priapism is a rare condition observed when an increase in penile arterial blood flow overwhelms the capacity of venous drainage; it is often associated with penile trauma, and does not require medical intervention. Ischemic priapism is associated with decreased venous return. In humans, ischemic priapism accounts for 95% of cases, the majority of which are idiopathic. Ischemic priapism is a urological emergency; simple conservative measures such as aspiration of blood from the corpora cavernosa and intracavernosal injection of an adrenergic agent are often successful. Stuttering priapism, also called recurrent or intermittent priapism, is a particular form of ischemic priapism reported in humans that is characterized by repetitive episodes of prolonged erections. Management consists of treating each new episode as an episode of acute ischemic priapism, and preventing recurrence with oral medications such as dutasteride and/or baclofen, gabapentin, or tadalafil. To the authors’ knowledge, this case is the first report of stuttering priapism in a dog. Full article
(This article belongs to the Section Veterinary Reproduction and Obstetrics)
Show Figures

Figure 1

8 pages, 2844 KB  
Case Report
Presumptive Non-Ischemic Priapism in a Cat
by Jeong-Min Lee, Ah-Won Sung, Han-Joon Lee, Joong-Hyun Song and Kun-Ho Song
Vet. Sci. 2022, 9(1), 29; https://doi.org/10.3390/vetsci9010029 - 14 Jan 2022
Cited by 1 | Viewed by 10181
Abstract
A 14-year-old neutered male British shorthair cat presented with a 21-day history of persistent erection and dysuria, along with overgrooming of the perineal region. Mild palpation induced pain and rigid corpora cavernosa with flaccid glans were observed during physical examination. Ultrasonography of the [...] Read more.
A 14-year-old neutered male British shorthair cat presented with a 21-day history of persistent erection and dysuria, along with overgrooming of the perineal region. Mild palpation induced pain and rigid corpora cavernosa with flaccid glans were observed during physical examination. Ultrasonography of the penis did not detect significant blood flow in the penile cavernosal artery. The drawing of aspirate blood from cavernosal bodies for gas analysis was impossible because of the anatomically small penis size of cats. Conservative management, including topical steroid ointment, lidocaine gel, gabapentin, and diazepam, was prescribed for supportive management. The clinical signs resolved, and ultrasonographic examination of the penis revealed no abnormalities. The cat remains clinically well without recurrence during the 6 months after treatment. To our knowledge, this is the first report of non-ischemic priapism in a cat. Full article
(This article belongs to the Special Issue Advances in Feline Internal Medicine)
Show Figures

Figure 1

Back to TopTop